)
)
)
Dan Salain
President & CEO,
Recall Therapeutics
United States
Industry veteran with over 28 years in Biotech and Pharmaceutical experience. Co-founder of Recall Therapeutics, Aceragen, Revel Next and Newport Veterinary Group. Successful VC fund raises of over $120M from Series A to Cross Over rounds. Completed exits in excess of $5B, Aceragen, Graybug, Aptalis, and Newport Led development & Commercialization of products Zenpep, Revel, Zimura, Medidate CD, Lamictal, and Amrix
Sessions
-
Recall Therapeutics02-Mar-2026Ballroom II C
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}